Skip to content

Effectiveness of TTNS in MS Patients With Lower Urinary Track Symptoms

Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation in Multiple Sclerosis Patients With Lower Urinary Track Symptoms: A Sham Controlled Prospective Randomized Controlled Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06263556
Enrollment
64
Registered
2024-02-16
Start date
2024-01-17
Completion date
2024-12-05
Last updated
2024-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Lower Urinary Tract Symptoms

Keywords

Multiple Sclerosis, Lower Urinary Track Symptoms, LUTS, Posterior tibial nerve stimulation, TPTNS, TTNS

Brief summary

Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. It is characterized with demyelinated plaques affecting subcortical, brain stem, and spinal cord nerve fibers. During the course of the disease, with the affection myelinated nerve tracks, lower urinary track symptoms may occur. 50-90% of the MS patients experience lower urinary track symptoms (LUTS) such as urinary incontinence, urgency, nocturia and/or urinary frequency during the at one point of their life. Aim of this study is to determine the effects of transcutaneous tibial nerve stimulation (TTNS) on symptoms and quality of life in MS patients with LUTS.

Detailed description

This is a single-centered, prospective, single blind, randomized controlled study of patients with MS who suffer lower urinary track symptoms. All patients will be informed of the details of all the procedures and of the details of the study. After the written informed consent is obtained, patients will be distributed to two equal groups using randomized number table. At the beginning and end of the study, post-void residue (PVR) will be calculated with ultrasonography, International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Incontinence Quality of Life( I-QOL), 3 day bladder diary (number of urination, urge, incontinence, nocturia) forms will be administered. Patients will be evaluated via PVR, urodynamic measurements, ICIQ-SF, I-QOL and bladder diary.

Interventions

Patients will be informed about pelvic floor muscles functions and written material will be given for home training. Exercise program will be planned as 1 set, 3 times per day. Each set will include 10 pelvic floor contractions. Patient will be instructed to squeeze their pelvic muscles and keep them contracted for 8 seconds. Due to fatigue and spasticity patients may experience, patients will set their own resting periods between contractions. Patients will be told to avoid contracting abdominal and gluteal muscles and avoid holding their breathe during the exercise. Patients will be instructed to perform exercise as following: 1. Lie on your back. Take a deep breathe. Relax your abdominal muscles as you breathe out. 2. Focus on your pelvic floor muscles. Squeeze your muscles as you are trying to stop the flow of your urine and stay contracted for 8 seconds, then relax. 3. Repeat when you feel ready. You need to repeat this 10 times. 4. Repeat this exercise 3 times per day

Patients in TTSN group will receive posterior tibial nerve stimulation based on the protocol explained before.

DEVICESham stimulation

Patients in sham stimulation group will receive sham stimulation based on the protocol explained before.

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Patients will be randomized and assigned to either group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Volunteer Adults (Age 18-50) * Diagnosis of Multiple Sclerosis * Expanded Disability Status Scale (EDSS) 0-6,5 * Lower urinary track symptoms (Urinary incontinence, urgency, nocturia and/or urinary frequency) * Diagnosis of bladder disfunction with Urodynamic study within 1 months

Exclusion criteria

* Age less then 18 * Pacemaker or implantable defibrillator usage * Diabetic polyuria * Bleeding diathesis or severe bleeding tendency * Pelvic floor disfunction or nerve damage effecting tibial nerve * Currently pregnant or planning pregnancy * Active urinary infection * Active malignancy * Severe mental disability * Cognitive deficit * Expanded Disability Status Scale (EDSS) greater than or equal to 7 * Unable to attend to TPTNS treatment 2 times a week * Urodynamic findings of bladder outlet obstruction * Surgical history because of urinary incontinence * Urologic surgical history because of lower urinary track disfunction or symptoms * Diagnosis of prostatic enlargement * Diagnosis of pelvic organ prolapse

Design outcomes

Primary

MeasureTime frameDescription
Incontinence Quality of Life (I-QOL)6 weeks (Before and after the treatment)I-QOL is used for evaluation of quality of life in patients with incontinence. It comprises 22 questions presented under three subscales: limiting behavior, psychosocial impact, and social embarrassment. All the questions are based on a five-point Likert scale (1 = a lot, 2 = quite a bit, 3 = moderate, 4 = a little, and 5 = not at all). Points obtained by each question are added together which results in a total point of 0 to 110. This total point is then recalculated to take a value between 0-100 for better understand. Higher scores indicate a better quality of life. Validation of turkish version is available.

Secondary

MeasureTime frameDescription
Post-void residue (PVR)6 weeks (Before and after the treatment)Post-void residue (PVR) will be calculated with ultrasonography. Evaluation will be made by same person in all patients after urination, in supine position transabdominally with 2-5 Mhz convex probe using E-Saote Mylab Seven (Italy) device.
Bladder diary6 weeks (Before and after the treatment)2 or 3 day bladder diary is recommended by European Association of Urology in patients with lower urinary track symptoms. Urination frequency, urgency, incontinence and nocturia will be evaluated using 3 day bladder diary.
International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)6 weeks (Before and after the treatment)ICIQ-SF allows the assessment of incontinence's severity, frequency and its impact on quality of life. ICIQ-SF scoring is also a practical and reliable method for baseline and post-treatment evaluation of patients with urge incontinence. It contains six questions. First and second questions are about demographics and the sixth question is about conditions that lead to incontinence. First, second and sixth questions have no point value. Total score varies between 0 and 21 and is obtained by adding third, fourth and fifth question's points. Higher scores indicate greater problems with incontinence. Validation of turkish version is available.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSibel CAGLAR
dr.sibelcaglar@gmail.com+905333365651
Backup ContactArda Can KASAP
drardakasap@gmail.com+905384590119

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026